CRON
Cronos Group Inc
NASDAQ · Pharmaceuticals
$2.64
+0.08 (+3.13%)
Open$2.56
Previous Close$2.56
Day High$2.66
Day Low$2.56
52W High$4.66
52W Low$2.27
Volume—
Avg Volume216.0K
Market Cap1.34B
P/E Ratio27.22
EPS$0.09
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,031.8% upside
Current
$2.64
$2.64
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 155.32M | 133.35M | 685.76M |
| Net Income | 54.22M | 41.89M | 79.65M |
| Profit Margin | 34.9% | 33.2% | 11.6% |
| EBITDA | -129,712,059 | -105,801,026 | 131.89M |
| Free Cash Flow | — | — | 54.82M |
| Rev Growth | +16.5% | +16.5% | -5.4% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |